CTSB and Parkinson disease: As far as we know, this study is the first to investigate the therapeutic potential of TAN loaded in a nanocarrier (CS-TAN-NLCs) in treatment of PD, to evaluate its antidepressant effect as well as to explore a new target for the neuro anti-inflammatory effect of TAN via inhibition of Cathepsin B.